Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection

Yael Friedman-Levi, Romana Hoftberger, Herbert Budka, Tehila Mayer-Sonnenfeld, Oded Abramsky, Haim Ovadia, Ruth Gabizon*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Background: Prions, composed of a misfolded protein designated PrPSc, are infectious agents causing fatal neurodegenerative diseases. We have shown previously that, following induction of experimental autoimmune encephalomyelitis, prion-infected mice succumb to disease significantly earlier than controls, concomitant with the deposition of PrPSc aggregates in inflamed white matter areas. In the present work, we asked whether prion disease acceleration by experimental autoimmune encephalomyelitis results from infiltration of viable prion-infected immune cells into the central nervous system.Methods: C57Bl/6 J mice underwent intraperitoneal inoculation with scrapie brain homogenates and were later induced with experimental autoimmune encephalomyelitis by inoculation of MOG35-55 in complete Freund's adjuvant supplemented with pertussis toxin. Spleen and lymph node cells from the co-induced animals were reactivated and subsequently injected into naïve mice as viable cells or as cell homogenates. Control groups were infected with viable and homogenized scrapie immune cells only with complete Freund's adjuvant. Prion disease incubation times as well as levels and sites of PrPSc deposition were next evaluated.Results: We first show that acceleration of prion disease by experimental autoimmune encephalomyelitis requires the presence of high levels of spleen PrPSc. Next, we present evidence that mice infected with activated prion-experimental autoimmune encephalomyelitis viable cells succumb to prion disease considerably faster than do mice infected with equivalent cell extracts or other controls, concomitant with the deposition of PrPSc aggregates in white matter areas in brains and spinal cords.Conclusions: Our results indicate that inflammatory targeting of viable prion-infected immune cells to the central nervous system accelerates prion disease propagation. We also show that in the absence of such targeting it is the load of PrPSc in the inoculum that determines the infectivity titers for subsequent transmissions. Both of these conclusions have important clinical implications as related to the risk of prion disease contamination of blood products.

Original languageAmerican English
Article number549
JournalJournal of Neuroinflammation
StatePublished - 21 Mar 2012
Externally publishedYes

Bibliographical note

Funding Information:
This work was funded by the Morasha ISF foundation and by the Agnes Ginges foundation.


  • Brain
  • EAE
  • Immune cells
  • Infiltrates
  • PrPsc
  • Prion
  • Spinal cord


Dive into the research topics of 'Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection'. Together they form a unique fingerprint.

Cite this